Provided by Tiger Trade Technology Pte. Ltd.

Health in Tech

0.7398
-0.0095-1.27%
Post-market: 0.73980.00000.00%18:45 EDT
Volume:38.87K
Turnover:28.34K
Market Cap:48.48M
PE:-11.33
High:0.7498
Open:0.7200
Low:0.6906
Close:0.7493
52wk High:3.57
52wk Low:0.6501
Shares:65.53M
Float Shares:20.30M
Volume Ratio:0.29
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0653
EPS(LYR):0.0200
ROE:-21.91%
ROA:-12.72%
PB:2.48
PE(LYR):36.99

Loading ...

Health In Tech reports Q1 EPS (3c), consensus (2c)

TIPRANKS
·
May 14

Health In Tech backs FY26 revenue view $45M-$50M, consensus $46.36M

TIPRANKS
·
May 14

Health In Tech Q1 EPS $(0.03), Inline, Sales $4.509M Miss $7.349M Estimate

Benzinga Earnings
·
May 14

Health In Tech Q1 FY26 turns to net loss of $1.6 million; revenue rises 9.4% to $8.8 million

Reuters
·
May 14

Press Release: Health In Tech Reports First Quarter 2026 Financial Results

Dow Jones
·
May 14

Health In Tech Inc expected to post a loss of 3 cents a share - Earnings Preview

Reuters
·
May 12

Press Release: Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA

Dow Jones
·
May 07

Health in Tech AI, marketing chief Dustin Plantholt departs amid business transition

Reuters
·
May 02

Health In Tech to report first-quarter results after market close May 13

Reuters
·
May 01

Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)

GlobeNewswire
·
Apr 30

Health In Tech files to sell 5.6M shares of Class A common stock for holders

TIPRANKS
·
Apr 25

Health In Tech to present at Market Movers Investor Summit

Reuters
·
Apr 22

Health In Tech Initiated at Buy by Craig-Hallum

Dow Jones
·
Apr 20

Health In Tech initiated with a Buy at Craig-Hallum

TIPRANKS
·
Apr 20

Health In Tech General Counsel John McStravock files initial beneficial ownership statement

Reuters
·
Apr 14